| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/19/2002 | US6358943 N-substituted indolines as estrogenic agents |
| 03/19/2002 | US6358942 Microbiocides and bactericides for treating grampositive, bacteroides, clostridium, mycobacterium, staphylococcus and streptococcus infections |
| 03/19/2002 | US6358941 Treatment of arthritis disorders, rheumatoid arthritis and manifestations associated with rheumatoid disorders |
| 03/19/2002 | US6358940 Modified 2-Alkoxyestradiol derivatives with prolonged pharmacological activity |
| 03/19/2002 | US6358939 Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| 03/19/2002 | US6358937 Administering phosphatidic acid and lipid to treat drug abuse, addiction, or withdrawal and/or alcoholism |
| 03/19/2002 | US6358934 Administering viricide to treat human t-cell leukemia/lymphoma and hepatitis virus infections; acquired immunodeficiency syndrome (aids) treatment |
| 03/19/2002 | US6358930 Treatment of C. difficile toxin B associated conditions |
| 03/19/2002 | US6358919 Polymer compounds comprising glycosphingosine |
| 03/19/2002 | US6358915 Administering uteroglobin as anticarcinogenic or antitumor agent to treat breast, lung or prostate cancer |
| 03/19/2002 | US6358741 Polynucleotide coding propagation regulator; for treating cell proliferative defects |
| 03/19/2002 | US6358704 M protein |
| 03/19/2002 | US6358698 Determing antipsychotic activity of compounds by exposing a serotonin receptor having wild type activity with a test compound; then measure basal activity of the receptor; decreased activity indicates antipsychotic drug compound |
| 03/19/2002 | US6358696 Methods of treatment of eye trauma and disorders |
| 03/19/2002 | US6358695 Determining compounds that activate or inhibit a g-protein receptor by exposing cells expressing the polypeptide on the surface with a test compound to allow binding and detect a signal in response to binding of agent to the polypeptide |
| 03/19/2002 | US6358539 To supplement collagen and elastic tissues and thicken the dermis to reduce or eliminate the appearance of cellulite |
| 03/19/2002 | US6358536 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 03/19/2002 | US6358528 Pharmaceutical formulation |
| 03/19/2002 | US6358527 Administering tablet comprising galanthamine hydrobromide, carrier comprising lactose monohydrate, microcrystalline cellulose and polymer disintegrant for therapy of dementia, mania or nicotine dependence |
| 03/19/2002 | US6358526 Forming a compactable granular mixture comprising compaction enhancing therapeutic compound that is different from compaction enhancing therapeutic compound and non-aesthetic excipients; compressing the granular mixture to form tablets |
| 03/19/2002 | US6358522 For reducing anal leakage of oil in a patient to whom orlistat is being administered |
| 03/19/2002 | US6358514 Combination of a retinoid with a histidine derivative |
| 03/19/2002 | US6358504 Compounds and compositions for delivering active agents |
| 03/19/2002 | US6358496 Protecting ultraviolet-sensitive organic materials against the damaging action of uv radiation by applying indoline compound |
| 03/19/2002 | US6358443 Directing microdroplets into freezing section containing a liquefied gas; contacting frozen microdroplets in extraction section with liquid non-solvent to extract solvent into non-solvent to form microparticles |
| 03/19/2002 | US6358060 Two-stage transmucosal medicine delivery system for symptom relief |
| 03/19/2002 | US6357163 Use of nucleic acid analogues in diagnostics and analytical procedures |
| 03/19/2002 | CA2251453C 5-arylalkyl-substituted pyrazolo(4,3-d)pyrimidine-7-ones |
| 03/19/2002 | CA2250036C Antibiotic cocktail and method of use |
| 03/19/2002 | CA2241981C Method of inhibiting photoaging of skin |
| 03/19/2002 | CA2236673C (-)cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 03/19/2002 | CA2232488C Cancer chemoprotective food products |
| 03/19/2002 | CA2231886C Copolymeric micelle drug composition and method for the preparation thereof |
| 03/19/2002 | CA2206804C Trisubstituted thioxanthines |
| 03/19/2002 | CA2193384C Use of gabapentin in the treatment of anxiety and panic |
| 03/19/2002 | CA2187110C Benzamide derivative, compositions containing said derivative and use thereof |
| 03/19/2002 | CA2179521C 2,4-disulphophenyl butylnitrone, its salts and their use as pharmaceuti cal spintraps |
| 03/19/2002 | CA2173963C Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 03/19/2002 | CA2157508C Ionene polymers as microbicides |
| 03/19/2002 | CA2151588C Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone |
| 03/19/2002 | CA2134560C Anti-obesity drugs |
| 03/19/2002 | CA2128359C New benzospiroalkene derivatives, their preparation process and pharmaceutical compositions containing them |
| 03/19/2002 | CA2128287C Benzospiroalkene derivatives, their preparation process and pharmaceutical compositions containing them |
| 03/19/2002 | CA2128078C Nutritional product for trauma and surgery patients |
| 03/19/2002 | CA2106975C Process for conditioning of water-soluble substances |
| 03/19/2002 | CA2101076C Glycosphingolipids |
| 03/19/2002 | CA2088909C Enzymic alteration of hair growth |
| 03/19/2002 | CA2084082C 1-pyperidinyl alkanoylarysulfonamide derivatives |
| 03/19/2002 | CA2079548C Carbamate derivatives of 4-amino-3- isoxazolidinones, 3-amino-1- hydroxypyrrolidin-2-ones and 1-amino-1- cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments |
| 03/19/2002 | CA2078885C Pharmaceutical compositions containing amethocaine |
| 03/19/2002 | CA2067733C Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure |
| 03/19/2002 | CA2055912C Novel erythromycin derivatives, their preparation process, the new intermediated obtained and their application as drugs |
| 03/19/2002 | CA2050331C Ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 03/19/2002 | CA2047347C Thioalkylthio cephalosporins derivatives |
| 03/19/2002 | CA2034569C Oral pharmaceutical forms of pimobendan |
| 03/19/2002 | CA2032797C Antithrombotic compounds |
| 03/19/2002 | CA2032303C Inhibitors of retroviral proteases |
| 03/19/2002 | CA2007075C New thrombolytic compositions |
| 03/18/2002 | CA2319928A1 Apoptosis-mimicking synthetic entities and use thereof in medical treatments |
| 03/15/2002 | CA2357155A1 Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| 03/14/2002 | WO2002020841A2 5-hydroxytryptamine receptor gene polymorphisms and response to treatment |
| 03/14/2002 | WO2002020822A2 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | WO2002020773A2 Chimeric antisense oligonucleotides of arabinofuranose analogues and deoxyribose nucleotides |
| 03/14/2002 | WO2002020762A2 Tnf receptor-like molecules and uses thereof |
| 03/14/2002 | WO2002020746A1 Lubricated granules |
| 03/14/2002 | WO2002020726A2 Method for increasing the effectiveness of antiinfective agents |
| 03/14/2002 | WO2002020724A2 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | WO2002020723A2 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | WO2002020722A2 Methods and compositions for in vitro targeting |
| 03/14/2002 | WO2002020622A1 A mixture of non-sulfated fucose-based oligosaccharides, a cosmetic or pharmaceutical composition comprising said mixture and its use in cosmetics or pharmacy |
| 03/14/2002 | WO2002020621A1 Tetraphenylporphyrin derivatives and compositions comprising the same |
| 03/14/2002 | WO2002020553A1 NOVEL POLYMORPHIC FORM OF 17-β-(N-TER.BUTYL CARBAMOYL)-4-AZA-5-α-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT |
| 03/14/2002 | WO2002020539A1 Adenosine derivatives and use thereof |
| 03/14/2002 | WO2002020532A1 Intermediates in cephalosporin production |
| 03/14/2002 | WO2002020530A1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 03/14/2002 | WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | WO2002020525A2 Protein tyrosine phosphatase inhibitor |
| 03/14/2002 | WO2002020524A1 Oxindole derivatives |
| 03/14/2002 | WO2002020522A1 Bicyclic enamide derivatives being integrin inhibitors |
| 03/14/2002 | WO2002020521A1 Use of indole derivatives for treating illnesses of the central nervous system |
| 03/14/2002 | WO2002020520A1 A thiazolidinedione derivative and its use as antidiabetic |
| 03/14/2002 | WO2002020519A1 The hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 03/14/2002 | WO2002020518A1 Thiazolidinone nitrate salt |
| 03/14/2002 | WO2002020517A1 A thiazolidinedione derivative and its use as antidiabetic |
| 03/14/2002 | WO2002020514A1 Multivalent neuraminidase inhibitor conjugates |
| 03/14/2002 | WO2002020513A1 Oxindole derivatives |
| 03/14/2002 | WO2002020512A1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 03/14/2002 | WO2002020505A1 Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain |
| 03/14/2002 | WO2002020504A1 Process for preparing epoxy compounds, aromatic compositions containing the compounds, and drinks, perfumes, cosmetics, cigarettes, and tobaccos containing the compositions |
| 03/14/2002 | WO2002020501A2 Polyarylcarboxamides useful as lipid lowering agents |
| 03/14/2002 | WO2002020497A1 Compounds having anti-hepatitis c virus effect |
| 03/14/2002 | WO2002020495A2 Inhibitors of glycogen synthase kinase 3 |
| 03/14/2002 | WO2002020492A1 Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor |
| 03/14/2002 | WO2002020489A2 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/14/2002 | WO2002020488A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
| 03/14/2002 | WO2002020486A2 Picolinic acid derivatives for the prevention and treatment of cancer in animals |
| 03/14/2002 | WO2002020485A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/14/2002 | WO2002020484A1 Chemical compounds |
| 03/14/2002 | WO2002020483A1 Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 03/14/2002 | WO2002020482A1 1-benzyl-4-[(5,6-dimethoxy-2-fluoro-1-indanon)-2-yl] methylpiperidine |